Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-14-006598
Filing Date
2014-05-30
Accepted
2014-05-30 17:04:33
Documents
10

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 78727
2 filename2.htm EX-4 9484
3 filename3.htm EX-10 144004
4 filename4.htm EX-10 184568
5 filename5.htm EX-10 152416
6 filename6.htm EX-10 129786
7 filename7.htm EX-10 21808
8 GRAPHIC g697983img1.jpg GRAPHIC 3627
9 GRAPHIC g6979831.jpg GRAPHIC 334279
10 GRAPHIC g69798322.jpg GRAPHIC 209415
  Complete submission text file 0000950123-14-006598.txt   1476285
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-00539 | Film No.: 14881177
SIC: 2834 Pharmaceutical Preparations